Study of Milademetan in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Clinical trial NCT03671564 · COMPLETED
Trial details
- NCT number
- NCT03671564
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-23
- Primary completion
- 2019-09-11
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.